X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2382) 2382
Publication (173) 173
Book Review (19) 19
Conference Proceeding (6) 6
Dissertation (2) 2
Book / eBook (1) 1
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2104) 2104
male (1285) 1285
neurosciences (1265) 1265
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (1245) 1245
mice (1118) 1118
parkinson's disease (1109) 1109
mptp (932) 932
dopamine - metabolism (739) 739
index medicus (735) 735
mice, inbred c57bl (719) 719
disease models, animal (688) 688
rats (663) 663
parkinsons-disease (661) 661
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology (615) 615
dopamine (609) 609
substantia-nigra (458) 458
neurons (445) 445
humans (432) 432
corpus striatum - drug effects (411) 411
corpus striatum - metabolism (407) 407
female (401) 401
tyrosine 3-monooxygenase - metabolism (376) 376
substantia nigra - drug effects (371) 371
oxidative stress (343) 343
brain (341) 341
neurons - drug effects (339) 339
pharmacology & pharmacy (335) 335
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mptp (322) 322
neurotoxicity (313) 313
substantia nigra - metabolism (306) 306
biochemistry & molecular biology (298) 298
substantia nigra (294) 294
parkinson disease, secondary - chemically induced (279) 279
analysis (262) 262
neurons - metabolism (262) 262
neurology (258) 258
dose-response relationship, drug (244) 244
motor activity - drug effects (244) 244
brain - metabolism (237) 237
substantia nigra - pathology (235) 235
dopaminergic-neurons (222) 222
neurodegeneration (218) 218
neuroprotection (217) 217
neuroprotective agents - pharmacology (217) 217
brain - drug effects (216) 216
immunohistochemistry (212) 212
clinical neurology (207) 207
time factors (206) 206
basal ganglia (204) 204
parkinsons disease (204) 204
parkinson’s disease (201) 201
striatum (200) 200
rat (189) 189
parkinson disease - metabolism (187) 187
parkinsonian disorders - chemically induced (183) 183
behavior, animal - drug effects (179) 179
mpp (175) 175
dopamine agents - pharmacology (170) 170
parkinsonism (170) 170
nervous system (164) 164
rat-brain (163) 163
neurodegenerative diseases (162) 162
disease (160) 160
apoptosis (158) 158
parkinsonian disorders - metabolism (158) 158
rats, sprague-dawley (158) 158
mouse model (157) 157
3,4-dihydroxyphenylacetic acid - metabolism (154) 154
neurons - pathology (154) 154
1-methyl-4-phenylpyridinium (153) 153
corpus striatum - pathology (153) 153
parkinson disease - pathology (152) 152
parkinsonian disorders - physiopathology (151) 151
macaca fascicularis (149) 149
in-vivo (146) 146
mouse (146) 146
rats, wistar (140) 140
parkinson disease - drug therapy (138) 138
cell biology (136) 136
neurotoxins - pharmacology (133) 133
pyridines - pharmacology (133) 133
alpha-synuclein (132) 132
parkinsonian disorders - drug therapy (132) 132
parkinsonian disorders - pathology (130) 130
movement disorders (128) 128
mptp poisoning - metabolism (128) 128
mptp poisoning (124) 124
dopamine - physiology (121) 121
biomedicine (117) 117
toxicity (117) 117
homovanillic acid - metabolism (116) 116
mptp poisoning - pathology (116) 116
analysis of variance (115) 115
cells, cultured (114) 114
dopaminergic neurons - drug effects (114) 114
tyrosine hydroxylase (114) 114
rodents (112) 112
parkinson disease (111) 111
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - administration & dosage (108) 108
l-dopa (107) 107
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Urology, The, ISSN 0022-5347, 2012, Volume 187, Issue 5, pp. 1890 - 1897
Purpose Overactive bladder is highly prevalent among patients with Parkinson disease. Adenosine is an important neurotransmitter in the central nervous system... 
Urology | adenosine | receptors | overactive | urinary bladder | Parkinson disease | ZM 241385 | dopamine | MICTURITION REFLEX | DETRUSOR HYPERREFLEXIA | A(2A) RECEPTORS | STIMULATION | receptors, dopamine | VOIDING DYSFUNCTION | LEVODOPA | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | URINARY SYMPTOMS | APOMORPHINE | UROLOGY & NEPHROLOGY | MOTOR COMPLICATIONS | urinary bladder, overactive | Parkinson Disease - complications | Triazoles - administration & dosage | Triazines - pharmacology | Urinary Bladder, Overactive - complications | Rats | Rats, Sprague-Dawley | Dose-Response Relationship, Drug | Triazoles - pharmacology | Adenosine A2 Receptor Antagonists - administration & dosage | Adenosine A2 Receptor Antagonists - pharmacology | Urinary Bladder, Overactive - drug therapy | Animals | Urinary Bladder, Overactive - physiopathology | Triazines - administration & dosage | Urination - drug effects | Female | Disease Models, Animal | Adenosine | Neurosciences | Parkinson's disease | Universities and colleges | Personal video recorders | Animal models | Adenosine receptors | Intravenous administration | Neurodegenerative diseases | 6-Hydroxydopamine | Central nervous system | quinpirole | Neurotransmitters | Dopamine D1 receptors | Urinary bladder | Adenosine A2A receptors | Intracerebroventricular administration | Urination | Dopamine D2 receptors | Movement disorders | Reflexes
Journal Article
International Journal of Biological Sciences, ISSN 1449-2288, 03/2014, Volume 10, Issue 4, pp. 350 - 357
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 04/2012, Volume 229, Issue 1, pp. 41 - 47
► MPTP caused impairments in working memory and recognition as well as neurodegeneration. ► Chronic MK-801 treatment prevents the above MPTP-induced deficits.... 
Glutamatergic system | MK-801 | Cognition | Parkinson's disease | NMDA receptor | Dementia | VISUAL HALLUCINATIONS | NMDA RECEPTORS | EPISODIC-LIKE MEMORY | D-CYCLOSERINE | SUBSTANTIA-NIGRA | NEUROSCIENCES | DISEASE BRAINS | GLUTAMATE RECEPTORS | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP | METABOLIC-CHANGES | OBJECT RECOGNITION | BEHAVIORAL SCIENCES | Medical colleges | Methyl aspartate
Journal Article
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 11/2012, Volume 36, Issue 9, pp. 3224 - 3234
Amantadine and dextromethorphan suppress levodopa (L-DOPA)-induced dyskinesia (LID) in patients with Parkinsons disease (PD) and abnormal involuntary movements... 
6-hydroxydopamine | Parkinson's disease | Serotonin | L-DOPA | Dyskinesia | DOPA-INDUCED DYSKINESIA | LEVODOPA-INDUCED DYSKINESIAS | ABNORMAL INVOLUNTARY MOVEMENTS | dyskinesia | SUBSTANTIA-NIGRA | NEUROSCIENCES | serotonin | IN-VIVO | MOTOR | EXPRESSION | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED PRIMATES | RODENT MODEL | AGONIST | Dextromethorphan - therapeutic use | Dyskinesias - drug therapy | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Rats, Wistar | Levodopa - therapeutic use | Dyskinesias - physiopathology | Rats | Male | Parkinsonian Disorders - chemically induced | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Dopamine Agents - therapeutic use | Oxidopamine | Amantadine - therapeutic use | Piperazines - pharmacology | Rats, Sprague-Dawley | Antiparkinson Agents - therapeutic use | Receptor, Serotonin, 5-HT1A - drug effects | Serotonin 5-HT1 Receptor Antagonists - therapeutic use | Animals | Parkinsonian Disorders - drug therapy | Receptors, N-Methyl-D-Aspartate - agonists | Cycloserine - pharmacology | Pyridines - pharmacology | Methyl aspartate | Neurosciences | Dopa | Drugs | Amantadine | Animal models | sensorimotor system | Neurodegenerative diseases | Glutamic acid receptors (ionotropic) | 6-Hydroxydopamine | Data processing | N-Methyl-D-aspartic acid receptors | Dextromethorphan | Cycloserine | Serotonin S1 receptors | Antagonism | Levodopa | N-Methyl-D-aspartic acid | Movement disorders
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 2009, Volume 32, Issue 3, pp. 443 - 458
Journal Article
Pharmacology, Biochemistry and Behavior, ISSN 0091-3057, 01/2012, Volume 100, Issue 3, pp. 413 - 418
In this study, we investigated the neuroprotective effects of asiaticoside, a triterpenoid saponin isolated from the Chinese medicinal herb , in the rats model... 
Redox | Neuroprotection | Bcl-2/Bax ratio | Parkinson's disease | Asiaticoside | CELLS | OXIDATIVE STRESS | INDUCED APOPTOSIS | MITOCHONDRIA | NEUROSCIENCES | INHIBITION | GLUTATHIONE | BIOCHEMISTRY | DISEASE | CHEMISTRY | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | EXTRACT | Neuroprotective Agents - therapeutic use | Rats, Wistar | Glutathione - metabolism | Triterpenes - therapeutic use | Male | Substantia Nigra - metabolism | RNA, Messenger - metabolism | Corpus Striatum - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Parkinsonian Disorders - drug therapy | Dopaminergic Neurons - metabolism | Lipid Peroxidation - drug effects | Dopaminergic Neurons - drug effects | bcl-2-Associated X Protein - genetics | Disease Models, Animal | Parkinsonian Disorders - physiopathology | Oxidation-Reduction | bcl-2-Associated X Protein - metabolism | Rats | Random Allocation | Nerve Tissue Proteins - genetics | Gene Expression Regulation - drug effects | Nerve Tissue Proteins - metabolism | Antioxidants - therapeutic use | Substantia Nigra - drug effects | Animals | Corpus Striatum - drug effects | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Proto-Oncogene Proteins c-bcl-2 - genetics | Liquid chromatography | Medicine, Herbal | Gene expression | Medicine, Botanic | Index Medicus | Saponins | Basal ganglia | Dopamine | Bax protein | Bcl-2 protein | Neurons | Herbal medicines | Substantia nigra | triterpenoids | Central nervous system diseases | Antioxidants | Neurotoxicity | Metabolites | Surgery | Neostriatum | MPTP | Movement disorders | Glutathione
Journal Article
Journal Article
Journal Article
Folia Histochemica et Cytobiologica, ISSN 0239-8508, 2012, Volume 50, Issue 2, pp. 228 - 238
Journal Article
by Pan, Q and Zhang, WM and Wang, JY and Luo, F and Chang, JY and Xu, RX
Journal of Korean Neurosurgical Society, ISSN 2005-3711, 02/2015, Volume 57, Issue 2, pp. 82 - 87
The aim of this study was to investigate voluntary wheel running behavior in the unilateral 6-hydroxydopamine (6-OHDA) rat model. Male Sprague-Dawley rats were... 
Medial forebrain bundle | 6-hydroxydopamine | rat | Voluntary wheel running behavior | Parkinson\'s disease | SYSTEM | SURGERY | Parkinson's disease | STIMULATION | Rat | DEPLETION | DOPAMINERGIC-NEURONS | LESIONS | CLINICAL NEUROLOGY | DEGENERATION | PROTECTS | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP | MICE | DEFICITS | Laboratory Investigation
Journal Article